These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2823189)

  • 1. Kinetic analysis of thyrotropin-releasing hormone binding in the central nervous system: evidence for receptor desensitization.
    Hawkins EF; Engel WK
    Neurosci Lett; 1987 Aug; 79(1-2):157-62. PubMed ID: 2823189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleotide regulation of receptor binding of thyrotropin-releasing hormone (TRH) in rat brain regions, retina and pituitary.
    Sharif NA; Burt DR
    Neurosci Lett; 1987 Oct; 81(3):339-44. PubMed ID: 2829061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone.
    Hawkins EF; Wade R; Engel WK
    J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.
    Vonhof S; Feuerstein GZ; Cohen LA; Labroo VM
    Eur J Pharmacol; 1990 May; 180(1):1-12. PubMed ID: 2163861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain.
    Funatsu KS; Inanaga K
    Peptides; 1987; 8(2):319-25. PubMed ID: 3035515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of thyrotropin-releasing hormone binding by monovalent cations and guanyl nucleotides.
    Hinkle PM; Kinsella PA
    J Biol Chem; 1984 Mar; 259(6):3445-9. PubMed ID: 6323425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications.
    Hawkins EF; Engel WK
    Life Sci; 1985 Feb; 36(6):601-11. PubMed ID: 2982071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN; Gulati A
    Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone (TRH): apparent receptor binding in rat spinal cord.
    Prasad C; Edwards RM
    Brain Res; 1984 Oct; 311(1):1-6. PubMed ID: 6091847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
    Phillips WJ; Hinkle PM
    Mol Pharmacol; 1989 Apr; 35(4):533-40. PubMed ID: 2539560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in brain thyrotropin-releasing hormone (TRH) mechanism of amygdaloid kindled rats.
    Kajita S; Nakashima M; Okamoto M; Sato M; Ogawa N
    Jpn J Psychiatry Neurol; 1986 Sep; 40(3):345-7. PubMed ID: 3033370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activities of thionated thyrotropin-releasing hormone analogs.
    Lankiewicz L; Bowers CY; Reynolds GA; Labroo V; Cohen LA; Vonhof S; Sirén AL; Spatola AF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):359-66. PubMed ID: 1314591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRH analog administration increases endogenous TRH levels in the central nervous system.
    Prasad C; Eloby-Childress S; Iriuchijima T; Wilber JF; Szirtes T; Kisfaludy L
    Neuroendocrinology; 1989 Feb; 49(2):219-22. PubMed ID: 2542830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin-releasing hormone (TRH) degradation in NIH:N mouse cerebral cortex and spinal cord.
    Schwartz TM; Turner JG; Brooks BR
    Neurosci Lett; 1986 Nov; 71(2):209-12. PubMed ID: 3097590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogs of thyrotropin-releasing hormone: hypotheses relating receptor binding to net excitation of spinal lower motor neurons.
    Hawkins EF; Beydoun SR; Haun CK; Engel WK
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1184-90. PubMed ID: 3019335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and distribution of 3H-(3MeHis2)thyrotropin releasing hormone receptors in rat brain.
    Simasko SM; Horita A
    Life Sci; 1982 May; 30(21):1793-9. PubMed ID: 6285110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.